3Ross R. Atherosclerosis-an inflammatory disease [J]. N Engl J Med, 1999, 340(2): 115-126.
4Shimada K, Mokuno H, Watanabe Y, et al. High prevalence of se- ropositivity for antibodies to Chlamydia-specifie lipopolysaceharide in patients with acute coronary syndrome [J]. J Cardiovase Risk, 2000, 7(3): 209-213.
5Bobryshev YV. Dendritic cells and their role in atherogenesis [J]. Lab Invest, 2010, 90(7): 970-984.
6Cybulsky MI, JongsU'a-Bilen J. Resident intimal dendritic ceils and the initiation of athcrosclerosls [J]. Curr Opin Lipidol, 2010, 21(5): 397-403.
7Galkina E, Ley K. Immune and inflammatory mechanisms of athero- sclerosis (a) [J]. Annu Rev lmmunol, 2009, 27:165-197.
8Gawaz M, Stellos K, Langer HF. Platelets modulate atheroganesis and progression of atherosclerotic plaques via interaction with pro- genitor and dendritic cells [J]. J Thromb Haemost, 2008, 6(2): 235-242.
9Cao X, Zhang W, He L, et al. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide de- livery to induce specific antitumor immunity [J]. J Immunol, 1998, 161(11): 6238-6244.
10Renier G, Skamene E, Desanctis J, et al. Dietary n-3 polyunsaturat- ed fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities [J]. Arterio- scler Thromb, 1993, 13(10): 1515-1524.
